Sanofi (SNY) Stock Analysis

November 11, 2026

This is a peer-relative look at Sanofi (SNY): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Pharmaceuticals, Biotechnology & Life Sciences peers, so every number reads in context rather than in isolation.

Company Profile

Sanofi (SNY) trades as an ADR rather than ordinary local shares — read it with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Company profile fields for Sanofi (SNY)
Profile Item	SNY
Name	Sanofi ADR
Country/Region	France
GICS Sector	Health Care
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
GICS Industry	Pharmaceuticals
GICS Sub-Industry	Pharmaceuticals
Market Capitalization	112.71 billion USD
Currency	USD
Exchange	Nasdaq
Listing Date	July 1, 2002
Security Type	ADR

Price Performance

Cumulative Growth

SNY

GSPC

Sanofi (SNY) vs. S&P 500 (GSPC): Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Sanofi (SNY) and S&P 500 (GSPC). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Sanofi (SNY) and S&P 500 (GSPC). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Sanofi (SNY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: SNY	Industry group median
Total Return (1Y)	2.73%	24.62%
Total Return (3Y, Annualized)	6.89%	20.37%
Total Return (5Y, Annualized)	3.16%	-4.02%

Risk Profile

Drawdown History

SNY

GSPC

Sanofi (SNY) vs. S&P 500 (GSPC): Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Sanofi (SNY) and S&P 500 (GSPC). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Sanofi (SNY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: SNY	Industry group median
Volatility (1Y, Annualized)	23.60%	66.36%
Beta (5Y)	0.28	0.93
Max Drawdown (5Y)	-33.52%	-80.19%

Risk-Adjusted Performance

Risk-Return Positioning

Each dot is a stock plotted by 1-year volatility (risk) and 1-year return. SNY is highlighted; the dashed line is the Capital Allocation Line from the risk-free rate through the industry median — dots above it are stronger on a risk-adjusted basis.

Risk-Adjusted Metrics

Sanofi (SNY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: SNY	Industry group median
Sharpe Ratio (1Y)	-0.07	0.36
Sortino Ratio (1Y)	-0.10	0.58

Profitability

ROE (TTM)

Sanofi (SNY) posts ROE of 5.72%, roughly around the peer group’s normal range. Shareholders’ equity is producing a return that looks broadly typical for the industry.

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.72%

Group distribution

Max: 109.18%
Q3: 6.23%
SNY: 5.72%
Median: -26.66%
Q1: -64.05%
Min: -167.77%

Largest peers

LLY: 86.02%
NVS: 24.33%
AZN: 22.57%
JNJ: 20.02%
SNY: 5.72%
MRK: 5.06%
ABBV: --

Where Sanofi (SNY) stands on ROE within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Net Margin (TTM)

Sanofi (SNY) keeps 8.20% of revenue as net profit, putting net margin in the upper peer quartile. After operating costs, interest, and taxes, more of each sales dollar reaches shareholders than it does at most industry peers.

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.20%

Group distribution

Max: 18.05%
SNY: 8.20%
Q3: 4.78%
Median: 0.00%
Q1: -4.14%
Min: -17.05%

Largest peers

LLY: 31.90%
AZN: 17.68%
NVS: 17.49%
JNJ: 16.20%
ABBV: 15.67%
SNY: 8.20%
MRK: 3.64%

Where Sanofi (SNY) stands on net margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Operating Margin (TTM)

Sanofi (SNY) turns 30.89% of revenue into operating profit, putting operating margin in the upper peer quartile. Before financing and taxes enter the picture, the day-to-day business keeps more of each sales dollar than most industry peers.

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

30.89%

Group distribution

Max: 83.12%
SNY: 30.89%
Q3: 14.77%
Median: 0.00%
Q1: -78.82%
Min: -207.40%

Largest peers

LLY: 53.66%
ABBV: 39.59%
MRK: 35.22%
NVS: 34.27%
SNY: 30.89%
AZN: 29.57%
JNJ: 25.74%

Where Sanofi (SNY) stands on operating margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Profitability Metrics

Sanofi (SNY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: SNY	Industry group median
ROE (TTM)	5.72%	-26.66%
ROA (TTM)	5.31%	-12.50%
Net Margin (TTM)	8.20%	0.00%
Operating Margin (TTM)	30.89%	0.00%
Gross Margin (TTM)	73.68%	37.87%

Growth

Revenue Growth

Sanofi (SNY) grew revenue 5.49%, roughly around the peer group's normal range. Top-line momentum looks broadly typical for the industry.

Sanofi (SNY): Revenue Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

EPS Growth

Sanofi (SNY) grew earnings per share 39.43%, roughly around the peer group's normal range. Bottom-line momentum looks broadly typical for the industry.

Sanofi (SNY): EPS Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

Growth Metrics

Sanofi (SNY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: SNY	Industry group median
Revenue Growth (YoY)	5.49%	11.45%
Revenue Growth (3Y CAGR)	4.82%	9.94%
EPS Growth (YoY)	39.43%	4.28%
EPS Growth (3Y CAGR)	6.02%	4.17%

Financial Strength

Current Ratio (MRQ)

Sanofi (SNY) has current ratio of 1.12, in the tighter-liquidity quartile for its industry. The short-term cushion is thinner than most peers carry, even if the absolute comfort level still depends on the business model.

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.12

Group distribution

Max: 25.13
Q3: 12.13
Median: 5.52
Q1: 2.47
SNY: 1.12
Min: 0.10

Largest peers

LLY: 1.39
MRK: 1.35
SNY: 1.12
JNJ: 1.02
AZN: 1.01
NVS: 0.88
ABBV: 0.87

Where Sanofi (SNY) stands on current ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Debt / Equity (MRQ)

Sanofi (SNY) has debt-to-equity ratio of 0.27, roughly in line with the peer group’s normal leverage range. Its mix of debt and equity looks typical for the industry.

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.27

Group distribution

Max: 1.42
Q3: 0.65
SNY: 0.27
Median: 0.15
Q1: 0.02
Min: 0.00

Largest peers

NVS: 1.29
LLY: 1.23
MRK: 1.20
AZN: 0.66
JNJ: 0.55
SNY: 0.27
ABBV: --

Where Sanofi (SNY) stands on debt-to-equity ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Financial Strength Metrics

Sanofi (SNY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: SNY	Industry group median
Current Ratio (MRQ)	1.12	5.52
Debt / Equity (MRQ)	0.27	0.15
Net Debt / EBITDA	0.96	1.08

Dividends

Dividend Yield (TTM)

Sanofi (SNY) pays no dividend, leaving dividend yield at 0.00% this period. Shareholders may still receive value through reinvestment or buybacks, but there is no dividend income to compare here.

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

Group distribution

SNY: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Largest peers

NVS: 2.88%
ABBV: 2.40%
MRK: 2.29%
JNJ: 1.94%
AZN: 1.73%
LLY: 0.49%
SNY: 0.00%

Where Sanofi (SNY) stands on dividend yield within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Payout Ratio (TTM)

Sanofi (SNY) has payout ratio of 119.86%, meaning dividends exceeded current-period earnings. The gap would need to be covered by cash, retained earnings, financing, or other sources, so earnings alone do not support the payout.

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

119.86%

Group distribution

SNY: 119.86%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Largest peers

MRK: 343.43%
SNY: 119.86%
ABBV: 117.35%
NVS: 90.46%
JNJ: 80.12%
AZN: 45.38%
LLY: 21.71%

Where Sanofi (SNY) stands on payout ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Metrics

Sanofi (SNY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: SNY	Industry group median
Dividend Yield (TTM)	0.00%	0.00%
Dividend Payout Ratio (TTM)	119.86%	0.00%

Valuation

P/E Ratio (TTM)

Sanofi (SNY) trades at P/E ratio of 23.40, near the industry’s usual earnings multiple. The stock is not showing a clear peer discount or premium on trailing earnings.

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

23.40

Group distribution

Max: 85.34
Q3: 43.46
Median: 26.69
SNY: 23.40
Q1: 13.30
Min: 0.07

Largest peers

MRK: 148.21
ABBV: 50.05
LLY: 43.95
JNJ: 41.92
NVS: 31.02
AZN: 26.37
SNY: 23.40

Where Sanofi (SNY) stands on P/E ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/S Ratio (TTM)

Sanofi (SNY) trades at 2.21 on P/S ratio, in the lower sales-valuation quartile for its industry. That points to a cheaper revenue stream than most peers, with margin quality still doing the heavy lifting.

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.21

Group distribution

Max: 58.18
Q3: 25.77
Median: 7.30
Q1: 3.01
SNY: 2.21
Min: 0.01

Largest peers

LLY: 13.95
ABBV: 7.80
JNJ: 6.69
MRK: 5.37
NVS: 5.35
AZN: 4.63
SNY: 2.21

Where Sanofi (SNY) stands on P/S ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/B Ratio (MRQ)

Sanofi (SNY) trades at 1.38 on P/B ratio, in the lower book-value quartile for its industry. Investors are paying less for the balance-sheet equity than they pay for most peers, with returns on that equity still central to the read.

SNY

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.38

Group distribution

Max: 13.53
Q3: 6.54
Median: 3.25
Q1: 1.69
SNY: 1.38
Min: -5.59

Largest peers

LLY: 29.96
NVS: 8.25
JNJ: 8.16
MRK: 8.06
AZN: 5.59
SNY: 1.38
ABBV: -112.34

Where Sanofi (SNY) stands on P/B ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Valuation Metrics

Sanofi (SNY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: SNY	Industry group median
P/E Ratio (TTM)	23.40	26.69
P/S Ratio (TTM)	2.21	7.30
P/B Ratio (MRQ)	1.38	3.25
Free Cash Flow Yield (TTM)	7.17%	-1.66%